Objective Benzodiazepines are commonly used for the treatment of tension-type headache (TTH) 
Introduction

Tension-type headache (TTH) is one of the most common primary headaches. Its lifetime prevalence in the general population ranges in different studies from 30 to 78% (1, 2). The infrequent subtype has very little impact on the individual and does not command much attention from the medical profession. However, frequent sufferers can encounter considerable disability that sometimes warrants expensive drugs and prophylactic medication.
The most widely used evidence-based drugs for the management of TTH are the non-steroidal anti-inflammatory drugs (NSAIDs) in acute treatment and antidepressants for preventive treatment (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Benzodiazepines are commonly used for the treatment of TTH (15) (16) (17) (18) , however, there are few randomized controlled trials (RCTs) recommending the use of these drugs (19) . Etizolam is a thienodiazepine derivative, which is a short-acting and ultra-rapidly eliminated benzodiazepine (20) and the only approved benzodiazepine for administration to TTH patients under the Japanese health insurance system. As for NSAIDs, Aspirin, acetaminophen and mefenamic acid (21) 
Patients and Methods
The study design was a multi-center RCT . 0 1 ) . Ho we v e r , t h e r e wa s n o s i g n i f i c a n t d i f f e r e n c e b e t we e n t h e NS AI D-E T a n d NS AI D g r o u p s . Da t a a r e me a n ± S D.
F i g u r e 2 . T o p : VAS f o r h e a d a c h e d e c r e a s e d f r o m 5 . 6 9 ± 2 . 3 6 t o 2 . 3 6 ± 2 . 0 9 i n t h e NS AI D-E T g r o u p ( N-E )
) . Ho we v e r , t h e r e wa s n o s i g n i f i c a n t d i f f e re n c e b e t we e n t h e NS AI D-E T a n d NS AI D g r o u p s . B o t t o m
F i g u r e 3 . He a d a c h e i mp r o v e d s i g n i f i c a n t l y i n t h e f e ma l e p a t i e n t s ( * p < 0 . 0 5 , ) o f t h e NS AI D-E T g r o u p ( N-E ) . Da t a a r e me a n ± S D.
T a b l e 1 . B a c k g r o u n d o f P a r t i c i p a t i n g S u b j e c t s a n d Ch a n g e i n VAS (Fig. 1) Fig. 2 
All data are expressed as mean±SD. Differences between groups in pre-and post-VAS changes were analyzed using repeated-measures analysis of variance (ANOVA). A P value of less than 0.05 denoted the presence of a statistically significant difference.
Results
Although 144 patients were included in the study, complete follow-up was possible in only 129 patients: 15 patients dropped out during the treatment period
). On the other hand, there was no significant difference between the NSAID-ET and NSAID groups in terms of overall efficacy for headache
F i g u r e 4 . T h e r e wa s n o s i g n i f i c a n t d i f f e r e n c e i n d e g r e e o f h e a d a c h e b e t we e n y o u n g a n d o l d p a t i e n t s . Da t a a r e me a n ± S D.
F i g u r e 5 . S h o u l d e r p a i n i mp r o v e d s i g n i f i c a n t l y i n t h e f ema l e p a t i e n t s ( * * p < 0 . 0 4 ) o f t h e NS AI D-E T g r o u p ( N-E ) . Da t a a r e me a n ± S D.
and shoulder pain. However, headache was improved significantly in female patients (n=88, p<0.05; Fig. 3) , and no difference in young and old patients (Fig. 4) . Shoulder pain was significantly improved in females (n=88, p<0.05; Fig. 5) or in young patients (n=73, p<0.04; Fig. 6 ) in the NSAID-ET group. Side effects were observed in 24.4% of patients, with sleepiness being the most common in the NSAID-ET group, however, no patient dropped out due to side effects (Table 2) .
Discussion
The most widely used evidence-based acute treatment for management of TTH is with NSAIDs. The analgesic agents [acetaminophen (3) (4) (5) (6) (7) , aspirin (3, 6) , ibuprofen (5, (7) (8) (9) (10) (11) (12) (13) , ketoprofen (6, 12, 13) , and naproxen (4, 12) ] are all effective as analgesics in TTH.
The underlying pain mechanisms in TTH are highly dynamic and both central and peripheral mechanisms seem to be important (23) . The exact contributions of the peripheral mechanism (muscle contraction) and central mechanism in TTH are still unclear. Benzodiazepines are commonly used for TTH treatment, as agents that address both the central and peripheral mechanisms (15) (16) (17) (18) . The efficacy of the benzodiazepine compound alprazolam has been confirmed for chronic TTH (19 
) i n t h e NS AI D-E T g r o u p ( N-E ) . Da t a a r e me a n ± S D.
T a b l e 2 . I n c i d e n c e o f Ad v e r s e E v e n t s self-referred patients tended to have better results (2) . The mean age of the sample was interrelated and negatively related to treatment outcome: patients with more chronic TTH and those who were older had less benefit from treatment (2) 
